Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia Salwa BakrMervat KhorshiedMona El-Ghamrawy Original Article 27 April 2019 Pages: 1805 - 1812
Colla corii asini might upregulate ZNF471 and THOC5 by KRAB domain–containing zinc-finger protein pathway and THO complex subunit 5 pathway to improve anemia of pregnant women with β-thalassemia Yanfang LiZhanfeng ZhangSongping Luo Original Article 16 May 2019 Pages: 1813 - 1826
Association of alpha hemoglobin–stabilizing protein (AHSP) gene mutation and disease severity among HbE—beta thalassemia patients Rudra RaySiddhesh Arun KalantriMaitreyee Bhattacharyya Original Article 13 June 2019 Pages: 1827 - 1834
Establishing and evaluating an auto-verification system of thalassemia gene detection results Xiaozhe LinBizhen ChengYongni Wang Original Article 05 April 2019 Pages: 1835 - 1844
The abnormal function of CD39+ regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia Yumeng LuLuya ChengYunfeng Cheng Original Article 01 June 2019 Pages: 1845 - 1854
In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies Behnaz PezeshkpoorM. GazorpakJ. Oldenburg Original Article 17 April 2019 Pages: 1855 - 1865
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients P. LambyD. WolffL. Prantl Original Article 16 April 2019 Pages: 1867 - 1875
Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation Yu-Qian SunYu WangXiao-Jun Huang Original Article 29 May 2019 Pages: 1877 - 1883
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice Giovanni CaocciOlga MulasMassimo Breccia Original Article 01 May 2019 Pages: 1885 - 1890
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life Matteo MolicaGioia ColafigliMassimo Breccia Original Article 11 May 2019 Pages: 1891 - 1904
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo Nidhi JyotsanaAmit SharmaMichael Heuser Original Article 18 May 2019 Pages: 1905 - 1918
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice Emilia ScalzulliMatteo MolicaMassimo Breccia Original Article 05 June 2019 Pages: 1919 - 1925
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents—a multicenter historical prospective study Ron RamOdelia AmitOfir Wolach Original Article 11 June 2019 Pages: 1927 - 1932
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis Massimo BrecciaLuigiana LucianoFrancesca Palandri Original Article 14 June 2019 Pages: 1933 - 1936
Clinical risk scores do not accurately identify a very high risk population with diffuse large B cell lymphoma—an analysis of 386 Portuguese patients Rita CoutinhoJ. LobatoM. Gomes da Silva Original Article 04 April 2019 Pages: 1937 - 1946
Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin’s lymphoma Francesco GaudioClaudia NardelliGiorgina Specchia Original Article 17 April 2019 Pages: 1947 - 1952
Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy Daniel Gutiérrez-SaboridoAlicia Gutiérrez-ValenciaGrupo de Estudio de Hepatitis Virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) Original Article 25 April 2019 Pages: 1953 - 1959
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients Andrea JanikovaRenata ChloupkovaMarek Trneny Original Article 08 May 2019 Pages: 1961 - 1972
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) Jérôme CornillonElisabeth DaguenetEmmanuel Gyan Original Article 20 May 2019 Pages: 1973 - 1980
Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan Naoyo IshikuraYoshiaki UsuiKeitaro Matsuo Original Article 08 June 2019 Pages: 1981 - 1987
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report Masaya TaniwakiShinya KatsutaniNoboru Hattori Letter to the Editor 12 February 2019 Pages: 1989 - 1990
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency Christine MoutonLionel LerouxMathieu Fiore Letter to the Editor 04 March 2019 Pages: 1991 - 1992
Patterns and utility of vitamin B12 and folate testing in patients with isolated thrombocytopenia Emma P. DeLougheryAishwarya RavindranRonald S. Go Letter to the Editor 15 March 2019 Pages: 1993 - 1994
Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman’s disease Kazutoshi EbisawaYosuke MasamotoMineo Kurokawa Letter to the Editor 13 February 2019 Pages: 1995 - 1997
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma Ryo NakagawaYasushi OnishiHideo Harigae Letter to the Editor 01 March 2019 Pages: 1999 - 2001
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus Zhili JinYini WangZhao Wang Letter to the Editor Open access 04 March 2019 Pages: 2003 - 2004
Clinicohematologic and cytogenetic profile in a rare case of pure erythroid leukemia Smeeta GajendraAnil Kumar YadavManorama Bhargava Letter to the Editor 11 March 2019 Pages: 2005 - 2007
Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia Hai ChengXue WangKai-lin Xu Letter to the Editor 20 March 2019 Pages: 2009 - 2011
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma M. BlanesJ. I. LorenzoJavier de la Rubia Letter to the Editor 16 March 2019 Pages: 2013 - 2015
Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma Andrea MarraGiovanni MartinoBrunangelo Falini Letter to the Editor 16 March 2019 Pages: 2017 - 2018
Detection of AML-specific TP53 mutations in bone marrow–derived mesenchymal stromal cells cultured under hypoxia conditions Marian MüllerRicarda GrafHeinz Sill Letter to the Editor Open access 02 April 2019 Pages: 2019 - 2020
Circulating cell-free DNA for response evaluation of intravascular lymphoma Dries DeerenMalaïka Van Der LindenJo Van Dorpe Letter to the Editor 06 April 2019 Pages: 2021 - 2023